同载维生素D3对静脉注射拉洛西芬输送系统的影响
Chih-Hao Chang1, Shu-Jyuan Yang2, Tai-Horng Young2
1Department of Orthopedics, National Taiwan University Hospital and National Taiwan University College of Medicine, No. 1, Section 1, Jen-Ai Road, Taipei 100, Taiwan.
Colloids and surfaces. B, Biointerfaces
|November 20, 2024
概括
这项研究开发了一种新型纳米药物,使用人体血清阿尔伯明纳米颗粒共同封装拉洛西芬和维生素D3. 这些纳米粒子增强了潜在的骨质疏松症治疗药物输送.
科学领域:
- 纳米医学是一种纳米医学.
- 药物输送系统 药物输送系统
- 生物技术是生物技术.
背景情况:
- 纳米医学比传统药物具有优势,包括改善生物可用性和患者遵守性.
- 基于人血清白蛋白 (HSA) 的纳米颗粒是可注射配方的多功能药物载体.
研究的目的:
- 在基于HSA的纳米颗粒 (Ral/VitaD/HSA/PSS NP) 中共同封装拉洛西芬和维生素D3,用于静脉注射.
- 评估开发的纳米粒子的特性,稳定性和药物释放概况.
- 评估共载纳米粒子在体外和体内治疗绝经后骨质疏松症的疗效.
主要方法:
- 使用冷化-水化方法制备Ral/VitaD/HSA/PSS NP.
- 描述了纳米粒子的物理和化学特性.
- 研究了raloxifene和维生素D3.3的体外和体内释放动力学.
- 评估生物相容性和血液相容性,包括对骨质细胞性酸酶活性的影响.
主要成果:
- 拉洛西芬和维生素D3成功地被封装在HSA纳米颗粒中,并在无形状态中分散.
- 纳米颗粒在冷化后稳定,适合长期储存.
- 这些纳米颗粒证明了生物相容性和血液相容性,增强了骨质细胞活性.
- 与口服药物相比,静脉输送Ral/VitaD/HSA/PSSNP提高了药物的生物利用率和停留时间.
结论:
- 拉洛西芬和维生素D3在HSA纳米颗粒中的联合封装提供了一个有前途的纳米药物配方.
- 这种配方解决了与这些药物的口服药物相关的低生物可用性问题.
- 开发的纳米药物具有治疗绝经后骨质疏松症的潜力.
相关概念视频
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.9K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.9K
Routes of Drug Administration: Parenteral
1.9K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
1.9K
Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K


